Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity

Creative Commons License

GUNAY M., CELIK G., GUNAY B. O. , AKTAS A., KARATEKIN G., Ovali F.

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, vol.78, no.5, pp.300-304, 2015 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 78 Issue: 5
  • Publication Date: 2015
  • Doi Number: 10.5935/0004-2749.20150079
  • Journal Name: ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.300-304

Abstract

Purpose: To evaluate 2-year outcomes following intravitreal bevacizumab (IVB) as monotherapy for aggressive posterior retinopathy of prematurity (APROP).